Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, announced that the...
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis delta virus (HDV) and other serious diseases, provided...
SLINGSHOT BIOSCIENCES, INC., the makers of synthetic control cells for cell analysis applications, including flow cytometry, enabling precise, reliable, and repeatable results, today announced...
Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced the release of an abstract by ESMO with preliminary results from the company’s Phase...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has been...
